These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 26904470

  • 1. Bone mineral density in young adult women with congenital adrenal hyperplasia.
    Raizada N, Jyotsna VP, Upadhyay AD, Gupta N.
    Indian J Endocrinol Metab; 2016; 20(1):62-6. PubMed ID: 26904470
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia.
    Guo CY, Weetman AP, Eastell R.
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):535-41. PubMed ID: 8977749
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia.
    King JA, Wisniewski AB, Bankowski BJ, Carson KA, Zacur HA, Migeon CJ.
    J Clin Endocrinol Metab; 2006 Mar; 91(3):865-9. PubMed ID: 16278269
    [Abstract] [Full Text] [Related]

  • 6. Bone mineral density and fractures in congenital adrenal hyperplasia: Findings from the dsd-LIFE study.
    Riehl G, Reisch N, Roehle R, Claahsen van der Grinten H, Falhammar H, Quinkler M.
    Clin Endocrinol (Oxf); 2020 Apr; 92(4):284-294. PubMed ID: 31886890
    [Abstract] [Full Text] [Related]

  • 7. Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia.
    Falhammar H, Filipsson Nyström H, Wedell A, Brismar K, Thorén M.
    Eur J Endocrinol; 2013 Mar; 168(3):331-41. PubMed ID: 23211577
    [Abstract] [Full Text] [Related]

  • 8. Bone Mass in Young Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.
    Espinosa Reyes TM, Leyva González G, Domínguez Alonso E, Falhammar H.
    Horm Res Paediatr; 2021 Mar; 94(1-2):1-8. PubMed ID: 34044395
    [Abstract] [Full Text] [Related]

  • 9. Effect of long-term glucocorticoid therapy on bone mineral density of the patients with congenital adrenal hyperplasia.
    Ünal S, Alikaşifoğlu A, Özön A, Gönç N, Kandemir N.
    Turk J Pediatr; 2020 Mar; 62(3):359-366. PubMed ID: 32558409
    [Abstract] [Full Text] [Related]

  • 10. Fractures and bone mineral density in adult women with 21-hydroxylase deficiency.
    Falhammar H, Filipsson H, Holmdahl G, Janson PO, Nordenskjöld A, Hagenfeldt K, Thorén M.
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4643-9. PubMed ID: 17878254
    [Abstract] [Full Text] [Related]

  • 11. Bone mineral density and body composition in prepubertal and adolescent patients with the classical form of 21-hydroxylase deficiency.
    Sahakitrungruang T, Wacharasindhu S, Supornsilchai V, Srivuthana S, Kingpetch K.
    J Med Assoc Thai; 2008 May; 91(5):705-10. PubMed ID: 18672636
    [Abstract] [Full Text] [Related]

  • 12. Correlation of Bone Mineral Parameters with Anthropometric Measurements and the Effect of Glucocorticoids on Bone Mineral Parameters in Congenital Adrenal Hyperplasia.
    Ganesh R, Suresh N, Janakiraman L, Ravikumar K.
    Indian J Pediatr; 2016 Feb; 83(2):126-30. PubMed ID: 26223873
    [Abstract] [Full Text] [Related]

  • 13. Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency.
    Sciannamblo M, Russo G, Cuccato D, Chiumello G, Mora S.
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4453-8. PubMed ID: 16926248
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.
    Koetz KR, Ventz M, Diederich S, Quinkler M.
    J Clin Endocrinol Metab; 2012 Jan; 97(1):85-92. PubMed ID: 21994966
    [Abstract] [Full Text] [Related]

  • 16. Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation.
    Ghannam NN, Hammami MM, Bakheet SM, Khan BA.
    Calcif Tissue Int; 1999 Jul; 65(1):23-8. PubMed ID: 10369729
    [Abstract] [Full Text] [Related]

  • 17. Use of an aromatase inhibitor in children with congenital adrenal hyperplasia: Impact of anastrozole on bone mineral density and visceral adipose tissue.
    Halper A, Sanchez B, Hodges JS, Dengel DR, Petryk A, Sarafoglou K.
    Clin Endocrinol (Oxf); 2019 Jul; 91(1):124-130. PubMed ID: 31070802
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pattern of bone mineral density in patients with sporadic idiopathic hypoparathyroidism.
    Laway BA, Goswami R, Singh N, Gupta N, Seith A.
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):405-9. PubMed ID: 16584512
    [Abstract] [Full Text] [Related]

  • 20. The effect of glucocorticoid replacement therapy on bone mineral density in children with congenital adrenal hyperplasia.
    Cetinkaya S, Kara C.
    J Pediatr Endocrinol Metab; 2011 Apr; 24(5-6):265-9. PubMed ID: 21823521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.